Literature DB >> 8392304

Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary?

S C Nelson1, C S Bruggers, J Kurtzberg, H S Friedman.   

Abstract

PURPOSE: Hyperleukocytosis secondary to acute leukemia is a medical emergency. Intracranial hemorrhage often leads to death in this setting. Early efforts to prevent this serious complication have included emergent cranial irradiation, with its associated morbidity when used in the young child. Currently, exchange transfusion and/or leukapheresis are employed to acutely lower the peripheral leukocyte count. PATIENTS AND METHODS: We report three infants with acute leukemia and hyperleukocytosis in whom intravenous hydration, alkalinization, and allopurinol therapy alone produced rapid and dramatic decreases in the peripheral leukocyte count.
RESULTS: The maximal decrease in leukocyte count averaged 88% within 70 h of starting conservative management. A fall in leukocyte count to < 100 x 10(9)/L was noted at an average of 15 h following hospitalization. No patient developed complications.
CONCLUSIONS: When comparing this approach to exchange transfusion and leukapheresis we find it to be both safe and effective. Children with hyperleukocytosis in association with acute lymphocytic leukemia who present without life-threatening complications of an extremely high leukocyte count can be safely and effectively managed with intravenous hydration, alkalinization, and allopurinol therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392304

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  4 in total

1.  Management of common oncologic emergencies.

Authors:  Rachna Seth; Abdus Sami Bhat
Journal:  Indian J Pediatr       Date:  2011-03-12       Impact factor: 1.967

2.  Therapeutic leukapheresis: 9-year experience in a University Hospital.

Authors:  Ingrid M Parra Salinas; Victoria P González Rodriguez; José A García-Erce
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

Review 3.  Management of stroke in cancer.

Authors:  Lisa R Rogers
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

4.  Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India.

Authors:  Anita A Tendulkar; Puneet A Jain; Abhaykumar Gupta; Nidhi Sharma; Anisha Navkudkar; Vijaya Patle
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.